Please login to the form below

Not currently logged in
Email:
Password:

oral myeloma therapy

This page shows the latest oral myeloma therapy news and features for those working in and with pharma, biotech and healthcare.

Takeda can't sway NICE on oral myeloma therapy Ninlaro

Takeda can't sway NICE on oral myeloma therapy Ninlaro

Drug not recommended for NHS use in England and Wales. NICE has stuck to its decision not to recommend Takeda's multiple myeloma therapy Ninlaro for routine use in the NHS ... standard in myeloma treatment and patients in the UK deserve to have access to

Latest news

  • Novel therapies for blood cancers showcased at ASH Novel therapies for blood cancers showcased at ASH

    Meanwhile, CAR-T therapy has also been shown for the first time at this year's ASH to have a therapeutic benefit in multiple myeloma. ... cancer. There was also encouraging new data for Takeda's multiple myeloma therapy Ninlaro (ixazomib; MLN9708), which

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics